Conditions: Schizophrenia
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 97
Healthy volunteers: no

Brief summary:
This is an outpatient study to evaluate the long-term safety, tolerability, and pharmacokinetics of cariprazine in patients with schizophrenia.

Detailed description:

Arms:
arm 1: Participants received cariprazine 1.5 mg capsule once, twice or three times a day depending on their response and tolerability

Interventions: intervention 1: Cariprazine
Intervention descriptions: intervention 1: Cariprazine was supplied in capsules.

Protocol document: